Mount Yale Investment Advisors LLC Buys 3,544 Shares of Corteva, Inc. (NYSE:CTVA)

Mount Yale Investment Advisors LLC grew its stake in Corteva, Inc. (NYSE:CTVA) by 64.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,026 shares of the company’s stock after purchasing an additional 3,544 shares during the period. Mount Yale Investment Advisors LLC’s holdings in Corteva were worth $521,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Redmont Wealth Advisors LLC bought a new stake in shares of Corteva in the 1st quarter valued at approximately $25,000. Acadian Asset Management LLC acquired a new position in shares of Corteva in the 1st quarter worth approximately $25,000. Rise Advisors LLC boosted its holdings in shares of Corteva by 2,522.2% in the 1st quarter. Rise Advisors LLC now owns 472 shares of the company’s stock worth $27,000 after acquiring an additional 454 shares in the last quarter. Albion Financial Group UT boosted its holdings in shares of Corteva by 77.2% in the 1st quarter. Albion Financial Group UT now owns 505 shares of the company’s stock worth $29,000 after acquiring an additional 220 shares in the last quarter. Finally, Ironwood Wealth Management Inc. boosted its holdings in shares of Corteva by 106.1% in the 1st quarter. Ironwood Wealth Management Inc. now owns 544 shares of the company’s stock worth $31,000 after acquiring an additional 280 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Corteva news, insider Samuel R. Eathington sold 31,686 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the completion of the transaction, the insider now owns 53,854 shares in the company, valued at approximately $3,104,144.56. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, SVP Cornel B. Fuerer sold 39,736 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the completion of the transaction, the senior vice president now directly owns 126,628 shares in the company, valued at approximately $7,269,713.48. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Samuel R. Eathington sold 31,686 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the transaction, the insider now owns 53,854 shares of the company’s stock, valued at $3,104,144.56. The disclosure for this sale can be found here. In the last 90 days, insiders sold 83,556 shares of company stock worth $4,795,016. Corporate insiders own 0.14% of the company’s stock.

Corteva Trading Up 0.1 %

Shares of CTVA traded up $0.07 during trading hours on Monday, reaching $55.46. The stock had a trading volume of 1,871,915 shares, compared to its average volume of 3,414,680. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.10. Corteva, Inc. has a 52 week low of $43.22 and a 52 week high of $58.76. The firm has a 50-day moving average of $53.68 and a 200 day moving average of $53.68. The company has a market cap of $38.65 billion, a P/E ratio of 70.32, a P/E/G ratio of 1.50 and a beta of 0.77.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The business had revenue of $4.49 billion during the quarter, compared to analysts’ expectations of $4.65 billion. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The firm’s quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.16 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 2.78 earnings per share for the current fiscal year.

Corteva Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 17th. Shareholders of record on Tuesday, September 3rd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.23%. This is a boost from Corteva’s previous quarterly dividend of $0.16. Corteva’s dividend payout ratio is 81.01%.

Analyst Ratings Changes

Several research analysts have recently commented on CTVA shares. BMO Capital Markets boosted their target price on Corteva from $64.00 to $67.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Royal Bank of Canada boosted their target price on Corteva from $62.00 to $64.00 and gave the stock an “outperform” rating in a report on Monday, May 6th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $57.00 target price (down from $58.00) on shares of Corteva in a report on Friday, April 12th. Mizuho reduced their price objective on Corteva from $61.00 to $60.00 and set a “buy” rating on the stock in a report on Tuesday, June 18th. Finally, Barclays upped their price objective on Corteva from $55.00 to $58.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus target price of $63.00.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.